HSIC Insider Trading

Insider Ownership Percentage: 1.14%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $2,847,875.06

Henry Schein Insider Trading History Chart

This chart shows the insider buying and selling history at Henry Schein by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$472ksoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$6M-$4M-$2M$0$2M$4M$6MTotal Insider BuyingTotal Insider Selling

Henry Schein Share Price & Price History

Current Price: $68.62
Price Change: Price Decrease of -0.78 (-1.12%)
As of 03/28/2025 05:00 PM ET

This chart shows the closing price history over time for HSIC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$68.62Closing price on 03/29/25:

SEC Filings (Institutional Ownership Changes) for Henry Schein (NASDAQ:HSIC)

96.62% of Henry Schein stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at HSIC by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$1.04Bbought$556MsoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$1B-$500M$0$500M$1BTotal InflowsTotal Outflows
Henry Schein logo
Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Read More on Henry Schein

Today's Range

Now: $68.62
Low: $68.55
High: $69.84

50 Day Range

MA: $74.62
Low: $68.62
High: $81.91

52 Week Range

Now: $68.62
Low: $63.67
High: $82.49

Volume

1,028,798 shs

Average Volume

1,573,330 shs

Market Capitalization

$8.52 billion

P/E Ratio

28.24

Dividend Yield

N/A

Beta

0.9

Who are the company insiders with the largest holdings of Henry Schein?

Henry Schein's top insider shareholders include:
  1. James P Breslawski (Vice Chairman)
  2. Stanley M Bergman (CEO)
  3. Michael S Ettinger (COO)
  4. Bradford C Connett (CEO)
  5. Lorelei Mcglynn (SVP)
  6. Mark E Mlotek (EVP)
  7. David B Brous Jr (CEO)
  8. Philip A Laskawy (Director)
Learn More about top insider investors at Henry Schein.

Who are the major institutional investors of Henry Schein?

Henry Schein's top institutional investors include:
  1. Vanguard Group Inc. — 11.81%
  2. Artisan Partners Limited Partnership — 5.24%
  3. Invesco Ltd. — 3.98%
  4. American Century Companies Inc. — 3.85%
  5. FMR LLC — 2.81%
  6. Geode Capital Management LLC — 2.54%
Learn More about top institutional investors of Henry Schein stock.

Which institutional investors are selling Henry Schein stock?

Within the previous quarter, HSIC stock was sold by these institutional investors:
  1. Swedbank AB
  2. Stifel Financial Corp
  3. Bank of Montreal Can
  4. American Century Companies Inc.
  5. The Manufacturers Life Insurance Company
  6. Nuance Investments LLC
  7. Bank of America Corp DE
  8. Zuckerman Investment Group LLC
In the previous year, company insiders that have sold Henry Schein company stock include:
  1. James P Breslawski (Vice Chairman)
  2. Stanley M Bergman (CEO)
  3. Michael S Ettinger (COO)
  4. Bradford C Connett (CEO)
Learn More investors selling Henry Schein stock.

Which institutional investors are buying Henry Schein stock?

In the last quarter, HSIC stock was bought by institutional investors including:
  1. Palestra Capital Management LLC
  2. Lyrical Asset Management LP
  3. Norges Bank
  4. Steadfast Capital Management LP
  5. Hudson Bay Capital Management LP
  6. National Bank of Canada FI
  7. Raymond James Financial Inc.
  8. Raymond James Financial Inc.